GALECTIN THERAPEUTICS INC (GALT)

Nasdaq Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Financial Position (from SEC Filings)

$14.1M
Cash & Equivalents
$3.9M
Quarterly Burn Rate
11 mo
Est. Cash Runway
$267M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

FDA-Related SEC Filings

DateTypeDescriptionLink
2026-06-23 8-K GALECTIN THERAPEUTICS INC (GALT) (CIK 0001133416) - EXHIBIT 99.1 EDGAR

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for GALT.

SEC EDGAR Filings

All SEC filings for GALECTIN THERAPEUTICS INC on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.